Department of Biochemistry and Molecular Biology, Institute for Medical Research Israel-Canada, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Department of Pharmacology and Experimental Therapeutics, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
J Allergy Clin Immunol. 2014 Aug;134(2):460-9. doi: 10.1016/j.jaci.2013.12.1075. Epub 2014 Feb 28.
The involvement of mitochondrial oxidative phosphorylation (OXPHOS) in mast cell exocytosis was recently suggested by the finding that mitochondria translocate to exocytosis sites upon mast cell activation. In parallel, mitochondrial signal transducer and activator of transcription 3 (STAT3) was found to be involved in ATP production. However, the regulation of mitochondrial STAT3 function and its connection to mast cell exocytosis is unknown.
We sought to explore the role played by mitochondrial STAT3 in mast cell exocytosis.
Experiments were performed in vitro with human and mouse mast cells and rat basophilic leukemia (RBL) cells and in vivo in mice. OXPHOS activity was measured after immunologic activation. The expression of STAT3, extracellular signal-regulated kinase 1/2, and protein inhibitor of activated STAT3 in the mitochondria during mast cell activation was determined, as was the effect of STAT3 inhibition on OXPHOS activity and mast cell function.
Here we show that mitochondrial STAT3 is essential for immunologically mediated degranulation of human and mouse mast cells and RBL cells. Additionally, in IgE-antigen-activated RBL cells, mitochondrial STAT3 was phosphorylated on serine 727 in an extracellular signal-regulated kinase 1/2-dependent manner, which was followed by induction of OXPHOS activity. Furthermore, the endogenous inhibitor of STAT3, protein inhibitor of activated STAT3, was found to inhibit OXPHOS activity in the mitochondria, resulting in inhibition of mast cell degranulation. Moreover, mice injected with Stattic, a STAT3 inhibitor, had a significant decrease in histamine secretion.
These results provide the first evidence of a regulatory role for mitochondrial STAT3 in mast cell functions, and therefore mitochondrial STAT3 could serve as a new target for the manipulation of allergic diseases.
最近的研究发现,线粒体在肥大细胞脱颗粒时向脱颗粒部位转移,提示线粒体氧化磷酸化(OXPHOS)参与了肥大细胞脱颗粒。与此同时,还发现线粒体信号转导和转录激活因子 3(STAT3)参与了 ATP 的产生。然而,线粒体 STAT3 功能的调节及其与肥大细胞脱颗粒的关系尚不清楚。
我们旨在探讨线粒体 STAT3 在肥大细胞脱颗粒中的作用。
在体外用人源和鼠源肥大细胞以及大鼠嗜碱性白血病(RBL)细胞进行实验,并在体内进行小鼠实验。通过免疫激活后测量 OXPHOS 活性。在肥大细胞激活过程中,检测 STAT3、细胞外信号调节激酶 1/2 和激活的 STAT3 蛋白抑制剂在线粒体中的表达,以及 STAT3 抑制对 OXPHOS 活性和肥大细胞功能的影响。
本研究表明,线粒体 STAT3 是免疫介导的人源和鼠源肥大细胞及 RBL 细胞脱颗粒所必需的。此外,在 IgE-抗原激活的 RBL 细胞中,STAT3 在线粒体中丝氨酸 727 发生磷酸化,依赖于细胞外信号调节激酶 1/2,随后诱导 OXPHOS 活性。此外,发现 STAT3 的内源性抑制剂激活的 STAT3 蛋白抑制剂抑制线粒体中的 OXPHOS 活性,导致肥大细胞脱颗粒受到抑制。此外,注射 STAT3 抑制剂 Stattic 的小鼠组胺分泌显著减少。
这些结果首次提供了线粒体 STAT3 调节肥大细胞功能的证据,因此线粒体 STAT3 可能成为控制过敏疾病的新靶点。